Search Results - "Glazkova, V E"

Therapy options for metastatic triple negative breast cancer by Glazkova, E. V., Frolova, M. A., Israelyan, E. R.

“…Metastatic triple-negative breast cancer remains the most unfavourable among all breast cancer subtypes from the prognostic point of view. Despite the active…”
Get full text

Clinical case of the use of oral metronomic vinorelbin in patient with metastatic Her2 negative breast cancer by Frolova, M. A., Glazkova, E. V., Stenina, M. B.

“…Endocrine therapy in combination with inhibitors of cyclin-dependent kinases 4/6 in first lines is the current standard of treatment of metastatic ER positive…”
Get full text

Combination of Ixabepilone and Capecitabine in Metastatic Triple Negative Breast Cancer. Clinical case by Glazkova, E. V., Frolova, M. A., Stenina, M. B.

“…Metastatic triple negative breast cancer is considered to be a chemosensitive malignancy especially in treatment-naïve setting. However, tumor cells are able…”
Get full text

PARP inhibitors in the treatment of metastatic breast cancer patients with germline BRCA1/2 mutations. Experience of treatment with talazoparib in clinical practice by Frolova, M. A., Glazkova, E. V., Stenina, M. B.

“…Germline BRCA1/2 mutations account for about 10% of all breast cancer. BRCA1/2 proteins are involved in homologous recombination - DNA double-strand break…”
Get full text

Ribociclib in the first-line therapy for metastatic hormone-dependent HER2-negative breast cancer in patients with intact ovarian function by S. F. Menshikova, M. A. Frolova, E. V. Glazkova, M. B. Stenina

“…Treatment of choice of metastatic hormone-dependent breast cancer regardless of age is hormone therapy (HT) even with visceral metastases. Now we have a new…”
Get full text

TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER by Zikiryakhodzhaev, A. D., Frolova, M. A., Rasskazova, E. A., Glazkova, E. V.

“…The rate of triple-negative breast cancer is 10–24  %, and in recent years it’s one of the most studied subtypes of breast cancer due to its clinical…”
Get full text

Evaluation of subclinical cardiotoxicity in patients with breast cancer and arterial hypertension in two regimens of anthracycline-containing chemotherapy by Avalyan, A A, Oshchepkova, E V, Saidova, M A, Shitov, V N, Glazkova, E V, Stenina, M B, Chazova, I E

“…Objective. To study of subclinical cardiotoxicity of two anthracycline-containing chemotherapy regimens in breast cancer patients with normotension and…”
Get full text

role of telehealth services in the treatment of rare disease: analysis of 1 year of work on the example of anal cancer by Gordeev, S. S., Fedyanin, M. Yu, Glazkova, E. V., Amosova, V. A., Petrovskiy, A. V.

“…Objective: to assess the potential need for telehealth consultations in regions for the treatment of patients diagnosed with anal cancer and to analyze the…”
Get full text

The structure of mytilan, a bioglycan-immunomodulator isolated from the mussel Crenomytilus grayanus by Ovodova, R G, Glazkova, V E, Mikheyskaya, L V, Molchanova, V I, Isakov, V V, Ovodov, Y S, Fernandez Molina, L E

“…Mytilan, isolated from the mantle of the mussel Crenomytilus grayanus and which possesses high immunomodulating activity, is a non-covalently linked complex of…”
Get more information

Experience of using talazoparib in the aggressive course of BRCA2-associated triple-negative breast cancer: a clinical observation by Tsareva, A. S., Lubennikova, E. V., Rumyantsev, A. A., Glazkova, E. V., Ganshina, I. P.

“…The median overall survival for patients with metastatic triple-negative breast cancer is about 12-14 months. Chemotherapy has been the only treatment option…”
Get full text

Clinical case on the use of oral vinorelbine in the treatment of disseminated estrogen receptor-positive HER2-negative breast cancer by Glazkova, E.V., Stenina, M.B.

“…Luminal B (HER2-negative) breast cancer is considered the most common type. The consistent prescription of hormone therapy lines for disseminated estrogen…”
Get full text

Chemotherapy-associated clinical dynamics of nosogenic reactions in breast and ovarian cancer model by Golovanova, E A, Ivanov, S V, Giatsintova, A A, Ilyina, N A, Rumyantsev, A A, Glazkova, E V

“…To study the clinical features, dynamics and factors of nosogenic reactions (NR) development in patients with breast and ovarian cancers at the stage of…”
Get more information

THE RESULTS OF MONITORING OF PARASITIC SITUATION IN THE SPECIALLY PROTECTED NATURAL TERRITORIES OF THE CENTRAL REGION OF RUSSIA (2014 - 2016) by I. I. Orlova, I. N. Belousova, A. S. Burenok, E. V. Glazkova

“…Objective of research. The purpose of the research - monitoring the parasitic situation in the specially protected natural areas to identify natural foci of…”
Get full text

Isolation and Characterization of New GalNAc/Gal-Specific Lectin from the Sea Mussel Crenomytilus Grayanus by Belogortseva, Nataliya I, Molchanova, Valentina I, Kurika, Alexander V, Skobun, Andrey S, Glazkova, Vera E

“…A lectin, Crenomytilus grayanus (CGL), was purified from sea mussel C. grayanus by affinity chromatography on acid-treated Sepharose 6B and following gel…”
Get full text

The lectin activity of mytilan, a bioglycan from mussels, and its effect on microbial adhesion to macroorganism cells by Zaporozhets, T S, Besednova, N N, Ovodova, R G, Glazkova, V E

“…One of the mechanisms of the protective action of a bioglycan isolated from the mantle of mussels of the species Crenomytalus grayanus in bacterial infections…”
Get more information

Effect of mytilane, a bioglycan from the mussel Crenomytilus grayanus, on the course and outcome of experimental flu infection by Tsybul'skiĭ, A V, Isachkova, L M, Ovodova, R G, Glazkova, V E, Besednova, N N, Orlova, T G

“…Materials characterizing the antiviral activity of Mytilane, manifested by the protection of 50-60% of mice infected with the lethal dose of influenza virus…”
Get more information

The immunomodulating action of mytilan in an experimental influenza infection by Tsybul'skiĭ, A V, Ovodova, R G, Glazkova, V E, Besednova, N N, Ovodov, Iu S, Orlova, T G, Shcheglovitova, O N, Minskaia, L A

“…The materials characterizing the immunomodulating activity of mytilan, a bioglycane from an industrial object of Japanese sea, Crenomytilus grayanus, in…”
Get more information

Effect of mytilan--a polysaccharide from Crenomytilus grayanus--on local suppurative processes by Krylova, N F, Ovodova, R G, Besednova, N N, Glazkova, V E, Molchanova, V I

“…The study on the effect of mytilan on the local suppurative processes caused by administration of a virulent staphylococcal culture to the mouse pad showed…”
Get more information